When Is An Investigator Brochure Not Required

Get eSignatures done in a snap

Prepare, sign, send, and manage documents from a single cloud-based solution.

What is when is an investigator brochure not required?

A when an investigator brochure is not required when there is already an existing comprehensive report or document that contains all the necessary information about the investigational product. This report or document should cover aspects such as the pharmacokinetics, pharmacodynamics, and toxicology of the product.

What are the types of when is an investigator brochure not required?

There are two types of situations when an investigator brochure is not required. The first type is when the investigational product is already approved for another indication, and the second type is when the investigational product is a new formulation of an already approved product.

Existing comprehensive report or document covering all necessary information
Investigational product approved for another indication
New formulation of an already approved product

How to complete when is an investigator brochure not required

To complete when an investigator brochure is not required, you need to ensure that all the necessary information about the investigational product is already available in the existing comprehensive report or document. Additionally, you should clearly state the type of situation that exempts the need for an investigator brochure.

01
Gather all relevant information about the investigational product
02
Ensure the information is comprehensive and covers all necessary aspects
03
Clearly state the type of situation exempting the need for an investigator brochure

pdfFiller empowers users to create, edit, and share documents online. Offering unlimited fillable templates and powerful editing tools, pdfFiller is the only PDF editor users need to get their documents done.

Thousands of positive reviews can’t be wrong

Read more or give pdfFiller a try to experience the benefits for yourself
5.0
Friendly friendly & easy to use.
Friendly friendly & easy to use. good that they have free trials so we can experience it before purchase it.
elly
5.0
I love that you can store your signature in the program.
What do you like best? I love that you can store your signature in the program. Also much more professional look over using a pen to fill forms. What do you dislike? The extra level of security when logging in slows you down a little. Its probably actually a good thing as your forms are stored in the system. Recommendations to others considering the product: I have tried to figure out ways to fill pdfs without signing on to this system, it was a foolish waste of time. I am not the type of person that signs on to programs like this, I always felt like they were scams. I am so very happy with this program, I wish that I had signed up for this much sooner. I am not even using all of the features of this program and Its totally worth every cent! What problems are you solving with the product? What benefits have you realized? When companies email me a form that needs to be filled out and returned, pdfFiller makes it so much quicker, easier and more professional
The Dry Boys of Albany
5.0
I had to type information into a PDF.
I had to type information into a PDF… I had to type information into a PDF document and I couldn't do it in Windows 10; I found pdf.filler.com and was able to type in my information easily!
Ana L.

Questions & answers

The IB should be reviewed annually and must be updated when any new and important information becomes available, such as when a drug has received marketing approval and can be prescribed for use commercially.
Essential documents are those documents that individually and collectively allow the evaluation of the conduct of a trial and the quality of the data generated.
Sponsor and Investigator must retain records for 2 years after marketing or 2 years after investigational use is discontinued and FDA notified. Also see VCU's record retention policy.
The Investigator's Brochure should identify countries where the investigational product has been approved and marketed. Any important information arising from the marketed use should be summarised (e.g. formulations, dosages, routes of administration, and adverse product reactions).
Clinical Protocols and Investigator Brochures: A detailed clinical study protocol, and Investigator Brochure are required sections of an IND application.
The essential documents that should be included in the ISF include: Trial Protocol. Participant Information Sheet and Consent Forms. Investigator Brochure. Regulatory documents, applications and approvals. Delegation Logs. Safety Reports. Correspondence between delegated site staff and Sponsor.